Cargando…
Statin-mediated disruption of Rho GTPase prenylation and activity inhibits respiratory syncytial virus infection
Respiratory syncytial virus (RSV) is a leading cause of severe respiratory tract infections in children. To uncover new antiviral therapies, we developed a live cell-based high content screening approach for rapid identification of RSV inhibitors and characterized five drug classes which inhibit the...
Autores principales: | Malhi, Manpreet, Norris, Michael J., Duan, Wenming, Moraes, Theo J., Maynes, Jason T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556396/ https://www.ncbi.nlm.nih.gov/pubmed/34716403 http://dx.doi.org/10.1038/s42003-021-02754-2 |
Ejemplares similares
-
Use of Synthetic Isoprenoids to Target Protein Prenylation and Rho GTPases in Breast Cancer Invasion
por: Chen, Min, et al.
Publicado: (2014) -
Rho-GTPase and Atherosclerosis: Pleiotropic Effects of Statins
por: Cai, Anping, et al.
Publicado: (2015) -
SmgGDS: An Emerging Master Regulator of Prenylation and Trafficking by Small GTPases in the Ras and Rho Families
por: Brandt, Anthony C., et al.
Publicado: (2021) -
Alveolar-like Macrophages Attenuate Respiratory Syncytial Virus Infection
por: Porto, Bárbara N., et al.
Publicado: (2021) -
Targeting Small
GTPases and Their Prenylation in Diabetes
Mellitus
por: Gendaszewska-Darmach, Edyta, et al.
Publicado: (2021)